Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the launch of the newly enhanced Cortellis CMC Intelligence™ solution, featuring a new post-approval variations module. The module for post-approval variations covers regulatory changes across multiple countries, offering meticulously curated requirements to streamline tracking. With this update, pharmaceutical, biotech, and generics companies can effortlessly navigate the regulatory process and prioritize essential actions.
Unrivaled Brands And People’s California Reach Settlement Terms To Terminate All Pending Litigation
Unrivaled Brands, Inc. (OTCQB: UNRV) entered into a binding term sheet to resolve outstanding litigation with People’s California, LLC, subject to final documentation.
